Drug evaluation: Therion's rV-PSA-TRICOM + rF-PSA-TRICOM prime-boost prostate cancer vaccine. [electronic resource]
- Current opinion in molecular therapeutics Apr 2007
- 183-9 p. digital
Publication Type: Journal Article
1464-8431
Cancer Vaccines--adverse effects Clinical Trials, Phase I as Topic Clinical Trials, Phase II as Topic Clinical Trials, Phase III as Topic Contraindications Drug Evaluation, Preclinical Humans Male Patents as Topic Prostatic Neoplasms--drug therapy Structure-Activity Relationship